CA
BNTX icon

Clearstead Advisors’s BioNTech BNTX Stock Holding History

Clearstead Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15
Closed -$1.37K – 2750
2025
Q1 		$1.37K Hold
15
– – ﹤0.01% 1954
2024
Q4 		$1.71K Buy
+15
New +$1.71K ﹤0.01% 1865
2024
Q3 		– Sell
-78
Closed -$6.27K – 2049
2024
Q2 		$6.27K Hold
78
– – ﹤0.01% 1649
2024
Q1 		$7.23K Sell
78
-217
-74% -$20.8K ﹤0.01% 1117
2023
Q4 		$31.1K Sell
295
-75
-20% -$7.56K ﹤0.01% 858
2023
Q3 		$40.2K Buy
370
+185
+100% +$20.5K ﹤0.01% 916
2023
Q2 		$20K Hold
185
– – ﹤0.01% 898
2023
Q1 		$23K Hold
185
– – ﹤0.01% 827
2022
Q4 		$27.8K Hold
185
– – ﹤0.01% 738
2022
Q3 		$25K Sell
185
-130
-41% -$19.9K ﹤0.01% 732
2022
Q2 		$47K Hold
315
– – ﹤0.01% 631
2022
Q1 		$54K Buy
315
+50
+19% +$8.4K ﹤0.01% 661
2021
Q4 		$68K Buy
265
+50
+23% +$13.7K ﹤0.01% 605
2021
Q3 		$59K Hold
215
– – ﹤0.01% 582
2021
Q2 		$48K Buy
+215
New +$40.5K ﹤0.01% 561

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Clearstead Advisors's BNTX Position: Q2 2025 in Review

Clearstead Advisors sold out of BioNTech (BNTX) in Q2 2025, closing a stake of 15 shares — an estimated $1.37K sold.

Clearstead Advisors first reported a position in BNTX in Q2 2021 and held it in 15 quarters. The position peaked at $68K in Q4 2021. 258 funds tracked by Wall St. Rank hold BNTX as of Q2 2025.

  • Clearstead Advisors reported no remaining BioNTech position as of Q2 2025 after selling out during the quarter.
  • Clearstead Advisors sold 15 BioNTech shares in Q2 2025, an estimated $1.37K.
  • Clearstead Advisors first reported a position in BioNTech in Q2 2021 and held it in 15 quarters.
  • Clearstead Advisors's BioNTech position peaked at $68K in Q4 2021.
  • 258 funds tracked by Wall St. Rank held BioNTech as of Q2 2025.

Based on Clearstead Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.